Nasdaq(NDAQ)
Search documents
argenx and Zai Lab Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy in China
GlobeNewswire News Room· 2024-11-11 12:30
First and only NMPA-approved treatment for patients with CIDP in China Second VYVGART Hytrulo indication approved in China November 11, 2024 – 7:30am ET Amsterdam, the Netherlands— argenx SE (Euronext & Nasdaq: ARGX) and Zai Lab Limited (Nasdaq: ZLAB; HKEX: 9688) today announced that China’s National Medical Products Administration (NMPA) approved the supplemental Biologics License Application (sBLA) for VYVGART Hytrulo 1,000mg (5.6ml)/vial [efgartigimod alfa injection (subcutaneous injection)] for the ...
2 Nasdaq Stocks Up 510% and 910% in 2 Years to Buy Now, According to Wall Street
The Motley Fool· 2024-11-11 09:45
Nvidia and Meta Platforms led the Nasdaq-100 higher over the last two years.The Nasdaq-100 tracks the performance of the 100 largest non-financial companies listed on the Nasdaq Stock Exchange. Component weighting is adjusted quarterly in March, June, and September, and the entire index is reconstituted annually in December.The Nasdaq-100 is heavily weighted toward the technology sector, a corner of the market where the rise of artificial intelligence (AI) has been particularly impactful. Indeed, Nvidia (NV ...
JPMorgan Nasdaq Equity Premium Income ETF: Good for Income, but It Comes With Risks
The Motley Fool· 2024-11-09 21:05
It sounds too good to be true: a growth oriented ETF investment that also offers a 9% dividend yield. Here's what you need to know about JEPQ.As a dividend investor, you'd probably be pretty happy if you owned an exchange-traded fund (ETF) that rose 15% in a year while offering a high-single-digit yield. That's exactly what the JP Morgan Nasdaq Equity Premium Income ETF (JEPQ 0.20%) provided investors over the last 52 weeks. Before you run out and buy this ETF, however, you need to understand that there are ...
MacKenzie Realty Capital, Inc. Announces Listing on Nasdaq
GlobeNewswire News Room· 2024-11-08 22:32
ORINDA, Calif., Nov. 08, 2024 (GLOBE NEWSWIRE) -- MacKenzie Realty Capital, Inc. (“MacKenzie” or the “Company”) is pleased to announce that the Company has received approval to list its common stock on the Capital Market tier of The Nasdaq Stock Market LLC (“Nasdaq”) under the symbol “MKZR”. Trading on Nasdaq is expected to commence with the open of trading on Monday, November 11th. Shareholders are not required to take any action as a result of the uplisting. Trading on Nasdaq will enhance the visibility a ...
Nvni Group Limited Receives Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
GlobeNewswire News Room· 2024-11-07 22:30
NEW YORK, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Nvni Group Limited (Nasdaq: NVNI) (“Nuvini”) received a notification letter on November 1, 2024, from Nasdaq’s Listing Qualifications Department, indicating the Company’s minimum bid price per share had been below $1.00 for 30 consecutive business days, failing to meet Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). The notification has no immediate effect on the Company’s Nasdaq listing, and shares continue to trade under “NVNI”. Under Nasda ...
BioHarvest Sciences shares to list on Nasdaq next week
Proactiveinvestors NA· 2024-11-07 22:00
About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government ...
Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements
GlobeNewswire News Room· 2024-11-07 14:09
IRVINE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a leading global provider of advanced medical diagnostics, announced that it has been granted an additional 180-day compliance period from the Nasdaq Stock Market LLC ("Nasdaq") to meet the minimum $1.00 per share bid price requirement for continued listing on the Nasdaq Capital Market. This extension allows Biomerica until May 5, 2025, to regain compliance. This extension was provided because Biomerica currently meets the oth ...
BioHarvest Sciences Announces Uplisting to the Nasdaq Global Market
Newsfile· 2024-11-07 13:30
BioHarvest Sciences Announces Uplisting to the Nasdaq Global MarketCommon Shares to Begin Trading on Nasdaq on Tuesday, November 12, 2024November 07, 2024 8:30 AM EST | Source: BioHarvest Sciences Inc.Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 7, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that the Nasdaq Stock Market LLC h ...
Trinity Biotech Regains Compliance with Nasdaq Listing Requirements
GlobeNewswire News Room· 2024-11-07 13:19
DUBLIN, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq Global Select: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced that on November 6, 2024, it received written notice from the Nasdaq Stock Market LLC (“Nasdaq”) confirming that the Company has regained compliance with the minimum market value of publicly held shares (“MVPHS”) requirement under Nasdaq Listing Rule 5450(b)(2)(C) (th ...
embecta Celebrates National Diabetes Awareness Month by Ringing Nasdaq Closing Bell
GlobeNewswire News Room· 2024-11-07 11:30
PARSIPPANY, N.J., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company, announced it will ring the Nasdaq Closing Bell today in recognition of National Diabetes Awareness Month in November, celebrating the strength, well-being, and individuality of people living with diabetes. Advocacy and professional groups including the Association of Diabetes Care & Education Specialists (ADCES), Beyond Type 1, Beyond Type 2, Camp Nejeda, Children with Diabetes, Diab ...